Jean Duvall
Director/Board Member at ONDINE BIOMEDICAL INC.
Net worth: 24 297 $ as of 2024-03-30
Profile
Jean Marie Duvall is the founder of Trizell Holding SA, Repronovo SA, and Amzell BV.
She currently holds the position of Senior Independent Non-Executive Director at Ondine Biomedical, Inc. since 2021, Director, Executive VP & Group General Counsel at Ferring International Center SA since 2006, and Non-Executive Director at Roquefort Therapeutics Plc since 2022.
Previously, she served as Co-Chairman at FerGene, Inc., Director & Executive Vice President at Ferring Pharmaceuticals, Inc., Director at CPSI Holdings Ltd., Director at Ferring Research Ltd., Director at Ferring Laboratories Ltd., Director at Ferring Pharmaceuticals SA, Director at Trizell Ltd., Director at CPSI Scotland Ltd., Director at FinVector Oy, Director at Kuopio Center For Gene & Cell Therapy Kct oy, Director at Gliotherapy Ltd., Director at International School of Lausanne, Director at Ferring Properties SA, and General Counsel at Elan Corp.
Plc.
She obtained her undergraduate degree from Case Western Reserve University and her graduate degree from The Ohio State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONDINE BIOMEDICAL, INC.
0.11% | 2023-12-04 | 207,934 ( 0.11% ) | 24 297 $ | 2024-03-30 |
Jean Duvall active positions
| Companies | Position | Start |
|---|---|---|
| ONDINE BIOMEDICAL INC. | Director/Board Member | 2021-12-06 |
| ROQUEFORT THERAPEUTICS PLC | Director/Board Member | 2022-04-04 |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Director/Board Member | - |
| Repronovo SA | Founder | - |
Former positions of Jean Duvall
| Companies | Position | End |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | General Counsel | - |
Ferring Laboratories Ltd.
 Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The private company is based in Middlesex, UK and was founded in 1980. | Director/Board Member | - |
Trizell Ltd.
 Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Director/Board Member | - |
| Trizell Holding SA | Founder | - |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Chairman | - |
Training of Jean Duvall
| Case Western Reserve University | Undergraduate Degree |
| The Ohio State University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ONDINE BIOMEDICAL INC. | Health Technology |
| ROQUEFORT THERAPEUTICS PLC | Health Technology |
| Private companies | 18 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
| CPSI Holdings Ltd. | |
| Ferring Research Ltd. | |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The private company is based in Middlesex, UK and was founded in 1980. | Health Technology |
Ferring Pharmaceuticals SA
 Ferring Pharmaceuticals SA BiotechnologyHealth Technology Ferring Pharmaceuticals SA develops and markets biopharmaceutical products. It provides products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. The company was founded by Frederik Paulsen Sr in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Trizell Ltd. engages in research and experimental development on biotechnology. The company was founded on April 14, 1997 and is headquartered in Chinnor, the United Kingdom. | Health Technology |
CPSI Scotland Ltd.
 CPSI Scotland Ltd. Financial ConglomeratesFinance Part of CPSI Holdings Ltd., CPSI Scotland Ltd. is a financial services provider. The private company is based in East Kilbride, UK. CPSI Scotland was founded in 2011. | Finance |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
FinVector Oy
 FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The private company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
| Kuopio Center For Gene & Cell Therapy Kct oy | |
| Trizell Holding SA | |
| Repronovo SA | |
| Amzell BV | |
| Gliotherapy Ltd. | |
| International School of Lausanne | |
| Ferring Properties SA |
- Stock Market
- Insiders
- Jean Duvall
